Closed Loop Glucose Control in Patients With Type 2 Diabetes
NCT: NCT05386849 · COMPLETED
Реклама
NCT IDNCT05386849
СтатусCOMPLETED
Дата начала2022-05-09
Завершение2022-07-19
Краткое описание
This is a proof of concept safety study of an artificial intelligence based closed loop glucose control system designed for use in the intensive care unit setting. The type 2 diabetic subjects in this study will have their glucose controlled to a range of 100-140 mg/dL by a novel artificial intelligence based closed loop glucose control system for a period of 24 hours. The subjects will consume three standardized meals during the 24 hour study period.
Официальный источник
Открыть на ClinicalTrials.gov →Данные получены через API ClinicalTrials.gov. Актуальный статус смотрите в официальной записи.